0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bromhidrosis Disease Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-11C13349
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bromhidrosis Disease Treatment Market Research Report 2023
BUY CHAPTERS

Global Bromhidrosis Disease Treatment Market Research Report 2025

Code: QYRE-Auto-11C13349
Report
May 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bromhidrosis Disease Treatment Market Size

The global market for Bromhidrosis Disease Treatment was valued at US$ 69.4 million in the year 2024 and is projected to reach a revised size of US$ 97 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Bromhidrosis Disease Treatment Market

Bromhidrosis Disease Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bromhidrosis Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bromhidrosis Disease Treatment.
The Bromhidrosis Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bromhidrosis Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bromhidrosis Disease Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bromhidrosis Disease Treatment Market Report

Report Metric Details
Report Name Bromhidrosis Disease Treatment Market
Accounted market size in year US$ 69.4 million
Forecasted market size in 2031 US$ 97 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Drugs Store
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Biovencer Healthcare, Boehringer Ingelheim International GmbH, Galderma SA, Hikma Pharmaceuticals, Ipsen Pharma, Johnson and Johnson, Journey Medical Corp, Medytox, Merz Pharma GmbH and Co. KGaA, Novartis AG, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bromhidrosis Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bromhidrosis Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Bromhidrosis Disease Treatment Market growing?

Ans: The Bromhidrosis Disease Treatment Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Bromhidrosis Disease Treatment Market size in 2031?

Ans: The Bromhidrosis Disease Treatment Market size in 2031 will be US$ 97 million.

Who are the main players in the Bromhidrosis Disease Treatment Market report?

Ans: The main players in the Bromhidrosis Disease Treatment Market are AbbVie, Biovencer Healthcare, Boehringer Ingelheim International GmbH, Galderma SA, Hikma Pharmaceuticals, Ipsen Pharma, Johnson and Johnson, Journey Medical Corp, Medytox, Merz Pharma GmbH and Co. KGaA, Novartis AG, Pfizer

What are the Application segmentation covered in the Bromhidrosis Disease Treatment Market report?

Ans: The Applications covered in the Bromhidrosis Disease Treatment Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the Bromhidrosis Disease Treatment Market report?

Ans: The Types covered in the Bromhidrosis Disease Treatment Market report are Topical Antiseptic, Antiperspirants, Botulinum Toxin

Recommended Reports

Disease Treatment

Skin Disorders

Bladder & Pulmonary

1 Bromhidrosis Disease Treatment Market Overview
1.1 Product Definition
1.2 Bromhidrosis Disease Treatment by Type
1.2.1 Global Bromhidrosis Disease Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Topical Antiseptic
1.2.3 Antiperspirants
1.2.4 Botulinum Toxin
1.3 Bromhidrosis Disease Treatment by Application
1.3.1 Global Bromhidrosis Disease Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Bromhidrosis Disease Treatment Market Size Estimates and Forecasts
1.4.1 Global Bromhidrosis Disease Treatment Revenue 2020-2031
1.4.2 Global Bromhidrosis Disease Treatment Sales 2020-2031
1.4.3 Global Bromhidrosis Disease Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bromhidrosis Disease Treatment Market Competition by Manufacturers
2.1 Global Bromhidrosis Disease Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bromhidrosis Disease Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bromhidrosis Disease Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bromhidrosis Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bromhidrosis Disease Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bromhidrosis Disease Treatment, Product Type & Application
2.7 Global Key Manufacturers of Bromhidrosis Disease Treatment, Date of Enter into This Industry
2.8 Global Bromhidrosis Disease Treatment Market Competitive Situation and Trends
2.8.1 Global Bromhidrosis Disease Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bromhidrosis Disease Treatment Players Market Share by Revenue
2.8.3 Global Bromhidrosis Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bromhidrosis Disease Treatment Market Scenario by Region
3.1 Global Bromhidrosis Disease Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bromhidrosis Disease Treatment Sales by Region: 2020-2031
3.2.1 Global Bromhidrosis Disease Treatment Sales by Region: 2020-2025
3.2.2 Global Bromhidrosis Disease Treatment Sales by Region: 2026-2031
3.3 Global Bromhidrosis Disease Treatment Revenue by Region: 2020-2031
3.3.1 Global Bromhidrosis Disease Treatment Revenue by Region: 2020-2025
3.3.2 Global Bromhidrosis Disease Treatment Revenue by Region: 2026-2031
3.4 North America Bromhidrosis Disease Treatment Market Facts & Figures by Country
3.4.1 North America Bromhidrosis Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bromhidrosis Disease Treatment Sales by Country (2020-2031)
3.4.3 North America Bromhidrosis Disease Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bromhidrosis Disease Treatment Market Facts & Figures by Country
3.5.1 Europe Bromhidrosis Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bromhidrosis Disease Treatment Sales by Country (2020-2031)
3.5.3 Europe Bromhidrosis Disease Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bromhidrosis Disease Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Bromhidrosis Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bromhidrosis Disease Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Bromhidrosis Disease Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bromhidrosis Disease Treatment Market Facts & Figures by Country
3.7.1 Latin America Bromhidrosis Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bromhidrosis Disease Treatment Sales by Country (2020-2031)
3.7.3 Latin America Bromhidrosis Disease Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bromhidrosis Disease Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Bromhidrosis Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bromhidrosis Disease Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bromhidrosis Disease Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bromhidrosis Disease Treatment Sales by Type (2020-2031)
4.1.1 Global Bromhidrosis Disease Treatment Sales by Type (2020-2025)
4.1.2 Global Bromhidrosis Disease Treatment Sales by Type (2026-2031)
4.1.3 Global Bromhidrosis Disease Treatment Sales Market Share by Type (2020-2031)
4.2 Global Bromhidrosis Disease Treatment Revenue by Type (2020-2031)
4.2.1 Global Bromhidrosis Disease Treatment Revenue by Type (2020-2025)
4.2.2 Global Bromhidrosis Disease Treatment Revenue by Type (2026-2031)
4.2.3 Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Bromhidrosis Disease Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bromhidrosis Disease Treatment Sales by Application (2020-2031)
5.1.1 Global Bromhidrosis Disease Treatment Sales by Application (2020-2025)
5.1.2 Global Bromhidrosis Disease Treatment Sales by Application (2026-2031)
5.1.3 Global Bromhidrosis Disease Treatment Sales Market Share by Application (2020-2031)
5.2 Global Bromhidrosis Disease Treatment Revenue by Application (2020-2031)
5.2.1 Global Bromhidrosis Disease Treatment Revenue by Application (2020-2025)
5.2.2 Global Bromhidrosis Disease Treatment Revenue by Application (2026-2031)
5.2.3 Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Bromhidrosis Disease Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Bromhidrosis Disease Treatment Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Biovencer Healthcare
6.2.1 Biovencer Healthcare Company Information
6.2.2 Biovencer Healthcare Description and Business Overview
6.2.3 Biovencer Healthcare Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Biovencer Healthcare Bromhidrosis Disease Treatment Product Portfolio
6.2.5 Biovencer Healthcare Recent Developments/Updates
6.3 Boehringer Ingelheim International GmbH
6.3.1 Boehringer Ingelheim International GmbH Company Information
6.3.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.3.3 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product Portfolio
6.3.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.4 Galderma SA
6.4.1 Galderma SA Company Information
6.4.2 Galderma SA Description and Business Overview
6.4.3 Galderma SA Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Galderma SA Bromhidrosis Disease Treatment Product Portfolio
6.4.5 Galderma SA Recent Developments/Updates
6.5 Hikma Pharmaceuticals
6.5.1 Hikma Pharmaceuticals Company Information
6.5.2 Hikma Pharmaceuticals Description and Business Overview
6.5.3 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product Portfolio
6.5.5 Hikma Pharmaceuticals Recent Developments/Updates
6.6 Ipsen Pharma
6.6.1 Ipsen Pharma Company Information
6.6.2 Ipsen Pharma Description and Business Overview
6.6.3 Ipsen Pharma Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ipsen Pharma Bromhidrosis Disease Treatment Product Portfolio
6.6.5 Ipsen Pharma Recent Developments/Updates
6.7 Johnson and Johnson
6.7.1 Johnson and Johnson Company Information
6.7.2 Johnson and Johnson Description and Business Overview
6.7.3 Johnson and Johnson Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Johnson and Johnson Bromhidrosis Disease Treatment Product Portfolio
6.7.5 Johnson and Johnson Recent Developments/Updates
6.8 Journey Medical Corp
6.8.1 Journey Medical Corp Company Information
6.8.2 Journey Medical Corp Description and Business Overview
6.8.3 Journey Medical Corp Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Journey Medical Corp Bromhidrosis Disease Treatment Product Portfolio
6.8.5 Journey Medical Corp Recent Developments/Updates
6.9 Medytox
6.9.1 Medytox Company Information
6.9.2 Medytox Description and Business Overview
6.9.3 Medytox Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medytox Bromhidrosis Disease Treatment Product Portfolio
6.9.5 Medytox Recent Developments/Updates
6.10 Merz Pharma GmbH and Co. KGaA
6.10.1 Merz Pharma GmbH and Co. KGaA Company Information
6.10.2 Merz Pharma GmbH and Co. KGaA Description and Business Overview
6.10.3 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product Portfolio
6.10.5 Merz Pharma GmbH and Co. KGaA Recent Developments/Updates
6.11 Novartis AG
6.11.1 Novartis AG Company Information
6.11.2 Novartis AG Description and Business Overview
6.11.3 Novartis AG Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis AG Bromhidrosis Disease Treatment Product Portfolio
6.11.5 Novartis AG Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Company Information
6.12.2 Pfizer Description and Business Overview
6.12.3 Pfizer Bromhidrosis Disease Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pfizer Bromhidrosis Disease Treatment Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bromhidrosis Disease Treatment Industry Chain Analysis
7.2 Bromhidrosis Disease Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bromhidrosis Disease Treatment Production Mode & Process Analysis
7.4 Bromhidrosis Disease Treatment Sales and Marketing
7.4.1 Bromhidrosis Disease Treatment Sales Channels
7.4.2 Bromhidrosis Disease Treatment Distributors
7.5 Bromhidrosis Disease Treatment Customer Analysis
8 Bromhidrosis Disease Treatment Market Dynamics
8.1 Bromhidrosis Disease Treatment Industry Trends
8.2 Bromhidrosis Disease Treatment Market Drivers
8.3 Bromhidrosis Disease Treatment Market Challenges
8.4 Bromhidrosis Disease Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Bromhidrosis Disease Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bromhidrosis Disease Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bromhidrosis Disease Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bromhidrosis Disease Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Bromhidrosis Disease Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bromhidrosis Disease Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bromhidrosis Disease Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bromhidrosis Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bromhidrosis Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bromhidrosis Disease Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bromhidrosis Disease Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Bromhidrosis Disease Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bromhidrosis Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bromhidrosis Disease Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bromhidrosis Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bromhidrosis Disease Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Bromhidrosis Disease Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Bromhidrosis Disease Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Bromhidrosis Disease Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Bromhidrosis Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bromhidrosis Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Bromhidrosis Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Bromhidrosis Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bromhidrosis Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bromhidrosis Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bromhidrosis Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Bromhidrosis Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Bromhidrosis Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bromhidrosis Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bromhidrosis Disease Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bromhidrosis Disease Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Bromhidrosis Disease Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Bromhidrosis Disease Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bromhidrosis Disease Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bromhidrosis Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bromhidrosis Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Bromhidrosis Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Bromhidrosis Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bromhidrosis Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bromhidrosis Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bromhidrosis Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Bromhidrosis Disease Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Bromhidrosis Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bromhidrosis Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bromhidrosis Disease Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Bromhidrosis Disease Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Bromhidrosis Disease Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bromhidrosis Disease Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Bromhidrosis Disease Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Bromhidrosis Disease Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Bromhidrosis Disease Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Bromhidrosis Disease Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Bromhidrosis Disease Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bromhidrosis Disease Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Bromhidrosis Disease Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Bromhidrosis Disease Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Bromhidrosis Disease Treatment Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Biovencer Healthcare Company Information
 Table 76. Biovencer Healthcare Description and Business Overview
 Table 77. Biovencer Healthcare Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Biovencer Healthcare Bromhidrosis Disease Treatment Product
 Table 79. Biovencer Healthcare Recent Developments/Updates
 Table 80. Boehringer Ingelheim International GmbH Company Information
 Table 81. Boehringer Ingelheim International GmbH Description and Business Overview
 Table 82. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product
 Table 84. Boehringer Ingelheim International GmbH Recent Developments/Updates
 Table 85. Galderma SA Company Information
 Table 86. Galderma SA Description and Business Overview
 Table 87. Galderma SA Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Galderma SA Bromhidrosis Disease Treatment Product
 Table 89. Galderma SA Recent Developments/Updates
 Table 90. Hikma Pharmaceuticals Company Information
 Table 91. Hikma Pharmaceuticals Description and Business Overview
 Table 92. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product
 Table 94. Hikma Pharmaceuticals Recent Developments/Updates
 Table 95. Ipsen Pharma Company Information
 Table 96. Ipsen Pharma Description and Business Overview
 Table 97. Ipsen Pharma Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Ipsen Pharma Bromhidrosis Disease Treatment Product
 Table 99. Ipsen Pharma Recent Developments/Updates
 Table 100. Johnson and Johnson Company Information
 Table 101. Johnson and Johnson Description and Business Overview
 Table 102. Johnson and Johnson Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Johnson and Johnson Bromhidrosis Disease Treatment Product
 Table 104. Johnson and Johnson Recent Developments/Updates
 Table 105. Journey Medical Corp Company Information
 Table 106. Journey Medical Corp Description and Business Overview
 Table 107. Journey Medical Corp Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Journey Medical Corp Bromhidrosis Disease Treatment Product
 Table 109. Journey Medical Corp Recent Developments/Updates
 Table 110. Medytox Company Information
 Table 111. Medytox Description and Business Overview
 Table 112. Medytox Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Medytox Bromhidrosis Disease Treatment Product
 Table 114. Medytox Recent Developments/Updates
 Table 115. Merz Pharma GmbH and Co. KGaA Company Information
 Table 116. Merz Pharma GmbH and Co. KGaA Description and Business Overview
 Table 117. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product
 Table 119. Merz Pharma GmbH and Co. KGaA Recent Developments/Updates
 Table 120. Novartis AG Company Information
 Table 121. Novartis AG Description and Business Overview
 Table 122. Novartis AG Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novartis AG Bromhidrosis Disease Treatment Product
 Table 124. Novartis AG Recent Developments/Updates
 Table 125. Pfizer Company Information
 Table 126. Pfizer Description and Business Overview
 Table 127. Pfizer Bromhidrosis Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Pfizer Bromhidrosis Disease Treatment Product
 Table 129. Pfizer Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Bromhidrosis Disease Treatment Distributors List
 Table 133. Bromhidrosis Disease Treatment Customers List
 Table 134. Bromhidrosis Disease Treatment Market Trends
 Table 135. Bromhidrosis Disease Treatment Market Drivers
 Table 136. Bromhidrosis Disease Treatment Market Challenges
 Table 137. Bromhidrosis Disease Treatment Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bromhidrosis Disease Treatment
 Figure 2. Global Bromhidrosis Disease Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bromhidrosis Disease Treatment Market Share by Type: 2024 & 2031
 Figure 4. Topical Antiseptic Product Picture
 Figure 5. Antiperspirants Product Picture
 Figure 6. Botulinum Toxin Product Picture
 Figure 7. Global Bromhidrosis Disease Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Bromhidrosis Disease Treatment Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Drugs Store
 Figure 11. Other
 Figure 12. Global Bromhidrosis Disease Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Bromhidrosis Disease Treatment Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Bromhidrosis Disease Treatment Sales (2020-2031) & (K Units)
 Figure 15. Global Bromhidrosis Disease Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 16. Bromhidrosis Disease Treatment Report Years Considered
 Figure 17. Bromhidrosis Disease Treatment Sales Share by Manufacturers in 2024
 Figure 18. Global Bromhidrosis Disease Treatment Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Bromhidrosis Disease Treatment Players: Market Share by Revenue in Bromhidrosis Disease Treatment in 2024
 Figure 20. Bromhidrosis Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Bromhidrosis Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Bromhidrosis Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 23. North America Bromhidrosis Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 24. United States Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Bromhidrosis Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 27. Europe Bromhidrosis Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Bromhidrosis Disease Treatment Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Bromhidrosis Disease Treatment Revenue Market Share by Region (2020-2031)
 Figure 35. China Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Bromhidrosis Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Bromhidrosis Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Bromhidrosis Disease Treatment Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Bromhidrosis Disease Treatment Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Bromhidrosis Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Bromhidrosis Disease Treatment by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Bromhidrosis Disease Treatment by Type (2020-2031)
 Figure 54. Global Bromhidrosis Disease Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Bromhidrosis Disease Treatment by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Bromhidrosis Disease Treatment by Application (2020-2031)
 Figure 57. Global Bromhidrosis Disease Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 58. Bromhidrosis Disease Treatment Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS